Niagen Bioscience (NAGE) Non-Current Deferred Tax Liability (2017 - 2019)

Niagen Bioscience (NAGE) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $218000.0 in Q4 2019.

• On a quarterly basis, Non-Current Deferred Tax Liability rose 59.12% year-over-year to $218000.0 in Q4 2019; TTM through Dec 2019 was $218000.0, a 59.12% increase from a year earlier, with the FY2019 full-year figure at $218000.0, up 59.12% from the prior year.
• Non-Current Deferred Tax Liability for Q4 2019 stood at $218000.0, up from $137000.0 in the prior quarter.
• Over the last five years, Non-Current Deferred Tax Liability for NAGE reached as high as $218000.0 in Q4 2019 and fell as low as $137000.0 in Q4 2018.
• Historically, Non-Current Deferred Tax Liability has averaged $166333.3 across 3 years, with a median of $144000.0 in 2017.
• Across the five-year window, Non-Current Deferred Tax Liability slipped 4.86% in 2018 and jumped 59.12% in 2019, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $144000.0 in 2017, then fell by 4.86% to $137000.0 in 2018, then soared by 59.12% to $218000.0 in 2019.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $218000.0 in Q4 2019, $137000.0 in Q4 2018, and $144000.0 in Q4 2017.